Sichenzia Ross Ference Kesner LLP Represents Cannabinoid Based Therapeutics Company in $12.3 Million Private Placement Led by Tuatara Capital Fund I, Ltd. By Sichenzia Ross Ference LLP | May 6, 2020 Private Cannabinoid Life Science Company $12,300,000 Series B Preferred Stock Led by Tuatara Capital Fund 1, L.P. March 2017 Read More
